MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Net loss andcomprehensive loss-$38,426K (25.40%↑ Y/Y)Surgical Glaucoma$75,724K (-0.23%↓ Y/Y)Dry Eye$1,639K (-58.65%↓ Y/Y)Loss before incometaxes-$38,416K (25.07%↑ Y/Y)Provision for income taxes$10K (-95.76%↓ Y/Y)Investment income$3,973K (-32.85%↓ Y/Y)Revenue$77,363K (-3.13%↓ Y/Y)Loss from operations-$37,099K (26.58%↑ Y/Y)Interest expense$5,142K (10.30%↑ Y/Y)Gross profit$66,666K (-2.37%↓ Y/Y)Other expense, net-$148K (-362.50%↓ Y/Y)Cost of goods sold$10,697K (-7.63%↓ Y/Y)Total operatingexpenses$103,765K (-12.67%↓ Y/Y)Selling, general andadministrative$89,159K (-11.57%↓ Y/Y)Research and development$14,606K (-18.81%↓ Y/Y)
Income Statement
source: myfinsight.com

Sight Sciences, Inc. (SGHT)

Sight Sciences, Inc. (SGHT)